Blockchain Registration Transaction Record

Annovis Bio Commences Phase 3 Trial for Alzheimer's Treatment

Annovis Bio (ANVS) starts Phase 3 trial for Alzheimer's treatment, secures new patent, and participates in key conferences. Cash reserves up, R&D expenses down. Learn more about the latest developments in neurodegenerative disease therapies.

Annovis Bio Commences Phase 3 Trial for Alzheimer's Treatment

This news matters as it highlights the progress made by Annovis Bio in developing innovative therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. The initiation of the Phase 3 trial signifies a significant step towards potentially addressing the unmet medical needs in these conditions, offering hope for improved brain function and quality of life for patients.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x5f0b08d4e373af2ded8a94154c3790ea4cdbba23620eba2c5c9dcba8b51969d6
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintenvylim9-e76affc1184c534c2ec572818a4eeec8